The product lifecycle is a classic concept that every marketer has encountered and studied at some point.
Traditionally, a product lifecycle is divided into four main stages: Introduction → Growth → Maturity → Decline. This is considered a “natural” development cycle, seemingly irreversible, with Decline assumed to be the inevitable end point.
However, in reality — especially in the pharmaceutical industry, a sector characterized by constant fluctuations and a high demand for flexibility — the product lifecycle does not simply stop there.
Healthcare: a dynamic market without fixed limits
Unlike fast-moving consumer goods (FMCG), the healthcare market has unique characteristics:
- Long product lifecycles, sometimes lasting decades.
- Strong dependency on treatment guidelines, health policies, and tender regulations.
- Continuously influenced by scientific advancements, new drug generations, and evolving treatment needs.
A pharmaceutical product can “revive” or enter a second growth phase thanks to various factors, such as:
- Updated treatment guidelines: Older products become first-line choices.
- Indication expansion: Approval for new indications opens additional markets.
- Policy changes: Shifts in tender regulations or insurance coverage create new advantages.
- Competition with new-generation drugs: Forces repositioning or combination indications.
- Deployment model transformation: From centralized hospitals to provincial or district hospitals.
Renewal: “reviving” the product lifecycle and establishing a new growth peak
In the pharmaceutical industry, Renewal is not just a tactic — it is becoming an essential part of long-term brand strategy.
Renewal allows products to surpass the Maturity plateau, establish a “new peak,” and significantly extend their lifecycle. This is a strategic turning point adopted by many leading brands instead of accepting inevitable Decline.
Some common Renewal strategies include:
- Adding new indications — Expanding markets: Going beyond a single condition to develop multiple therapeutic indications.
- Repositioning — Changing segments: Transitioning from foundational treatment to combination therapy, or shifting from major hospitals to smaller clinics.
- Transforming deployment models: Expanding reach to provincial and district hospitals for deeper, broader access.
- Expanding portfolios — Integrating services: Developing comprehensive solutions (product-service bundles), enhancing therapeutic value, and strengthening ecosystem engagement.
As a result, products not only avoid decline but also unlock new market potential, reinforce competitive positioning, and maximize commercial value.
From inevitable “Decline” to proactive “Renewal”
Where Decline was once seen as an unavoidable phase, today, Renewal has become a strategically planned option.
The question is no longer “Should we extend the product lifecycle?” but “How well are we prepared for Renewal?”
Thus, instead of waiting for the product to hit bottom before “resuscitating,” pharmaceutical brand managers and marketing teams must proactively:
- Develop flexible engagement models, ready to shift strategies.
- Continuously update market data and policies.
- Analyze treatment data, disease trends, and unmet needs.
Re-examine the lifecycle: earlier, deeper, and more precisely
In an ever-changing market, continuously evaluating the product lifecycle not only helps maintain growth but also serves as a critical tool to anticipate risks and identify strategic opportunities.
Some essential questions pharmaceutical brands should ask themselves:
- What are the early signs that the product is peaking?
- Are there new indications or treatment guidelines about to be approved?
- Are the current distribution channels still effective? Can they be expanded?
- Are there any “white spaces” in the market yet to be explored?
The real limit does not lie in the graph
In the healthcare market, the true limit does not exist in the curves of a graph — it lies in how well a company understands the market, interprets data, and makes decisions.
Proactively developing a Renewal strategy not only extends a product’s lifecycle but also demonstrates the brand’s creativity and long-term strategic thinking.
Have you prepared a Renewal strategy for your product yet?
Learn more about the here.